The University of Chicago Header Logo

Connection

Ryan Widau to ErbB Receptors

Back to Details
This is a "connection" page, showing publications Ryan Widau has written about ErbB Receptors.
Ryan Widau
Connection Strength
0.031
ErbB Receptors
  1. Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results. Clin Lung Cancer. 2018 05; 19(3):213-220.e4.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.